| Immune self-reactivity triggered by drug-modified HLA-peptide repertoire PT Illing, JP Vivian, NL Dudek, L Kostenko, Z Chen, M Bharadwaj, ... Nature 486 (7404), 554-558, 2012 | 753 | 2012 |
| Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: implications for vaccine development. R Khanna, SR Burrows, MG Kurilla, CA Jacob, IS Misko, TB Sculley, ... The Journal of experimental medicine 176 (1), 169-176, 1992 | 485 | 1992 |
| A structural basis for the selection of dominant αβ T cell receptors in antiviral immunity L Kjer-Nielsen, CS Clements, AW Purcell, AG Brooks, JC Whisstock, ... Immunity 18 (1), 53-64, 2003 | 421 | 2003 |
| Activation and adoptive transfer of Epstein–Barr virus-specific cytotoxic T cells in solid organ transplant patients with posttransplant lymphoproliferative disease R Khanna, S Bell, M Sherritt, A Galbraith, SR Burrows, L Rafter, B Clarke, ... Proceedings of the National Academy of Sciences 96 (18), 10391-10396, 1999 | 385 | 1999 |
| Dominant selection of an invariant T cell antigen receptor in response to persistent infection by Epstein-Barr virus. VP Argaet, CW Schmidt, SR Burrows, SL Silins, MG Kurilla, DL Doolan, ... The Journal of experimental medicine 180 (6), 2335-2340, 1994 | 335 | 1994 |
| T cell receptor recognition of a'super-bulged'major histocompatibility complex class I–bound peptide FE Tynan, SR Burrows, AM Buckle, CS Clements, NA Borg, JJ Miles, ... Nature immunology 6 (11), 1114-1122, 2005 | 330 | 2005 |
| An alloresponse in humans is dominated by cytotoxic T lymphocytes (CTL) cross-reactive with a single Epstein-Barr virus CTL epitope: implications for graft-versus-host disease. SR Burrows, R Khanna, JM Burrows, DJ Moss The Journal of experimental medicine 179 (4), 1155-1161, 1994 | 329 | 1994 |
| HLA-B27–restricted antigen presentation in the absence of tapasin reveals polymorphism in mechanisms of HLA class i peptide loading CA Peh, SR Burrows, M Barnden, R Khanna, P Cresswell, DJ Moss, ... Immunity 8 (5), 531-542, 1998 | 325 | 1998 |
| Immune regulation in Epstein-Barr virus-associated diseases R Khanna, SR Burrows, DJ Moss Microbiological reviews 59 (3), 387-405, 1995 | 312 | 1995 |
| T cell allorecognition via molecular mimicry WA Macdonald, Z Chen, S Gras, JK Archbold, FE Tynan, CS Clements, ... Immunity 31 (6), 897-908, 2009 | 296 | 2009 |
| Role of cytotoxic T lymphocytes in Epstein-Barr virus-associated diseases R Khanna, SR Burrows Annual Reviews in Microbiology 54 (1), 19-48, 2000 | 270 | 2000 |
| Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein‐Barr virus latent membrane protein‐1: coordinate up‐regulation of peptide transporters and … M Rowe, R Khanna, CA Jacob, V Argaet, A Kelly, S Powis, M Belich, ... European journal of immunology 25 (5), 1374-1384, 1995 | 252 | 1995 |
| IMGT/HighV QUEST paradigm for T cell receptor IMGT clonotype diversity and next generation repertoire immunoprofiling S Li, MP Lefranc, JJ Miles, E Alamyar, V Giudicelli, P Duroux, JD Freeman, ... Nature communications 4 (1), 2333, 2013 | 246 | 2013 |
| AT cell receptor flattens a bulged antigenic peptide presented by a major histocompatibility complex class I molecule FE Tynan, HH Reid, L Kjer-Nielsen, JJ Miles, MCJ Wilce, L Kostenko, ... Nature immunology 8 (3), 268-276, 2007 | 242 | 2007 |
| A naturally selected dimorphism within the HLA-B44 supertype alters class I structure, peptide repertoire, and T cell recognition WA Macdonald, AW Purcell, NA Mifsud, LK Ely, DS Williams, L Chang, ... The Journal of experimental medicine 198 (5), 679-691, 2003 | 229 | 2003 |
| Identification of cytotoxic T cell epitopes within Epstein‐Barr virus (EBV) oncogene latent membrane protein 1 (LMP1): evidence for HLA A2 supertype‐restricted immune … R Khanna, SR Burrows, J Nicholls, LM Poulsen European journal of immunology 28 (2), 451-458, 1998 | 229 | 1998 |
| Cytotoxic T-cell clones discriminate between A-and B-type Epstein-Barr virus transformants DJ Moss, IS Misko, SR Burrows, K Burman, R McCarthy, TB Sculley Nature 331 (6158), 719-721, 1988 | 221 | 1988 |
| T cell receptor repertoire for a viral epitope in humans is diversified by tolerance to a background major histocompatibility complex antigen. SR Burrows, SL Silins, DJ Moss, R Khanna, IS Misko, VP Argaet The Journal of experimental medicine 182 (6), 1703-1715, 1995 | 210 | 1995 |
| High resolution structures of highly bulged viral epitopes bound to major histocompatibility complex class I: implications for T-cell receptor engagement and T-cell immunodominance FE Tynan, NA Borg, JJ Miles, T Beddoe, D El-Hassen, SL Silins, ... Journal of Biological Chemistry 280 (25), 23900-23909, 2005 | 208 | 2005 |
| The CDR3 regions of an immunodominant T cell receptor dictate the'energetic landscape'of peptide-MHC recognition NA Borg, LK Ely, T Beddoe, WA Macdonald, HH Reid, CS Clements, ... Nature immunology 6 (2), 171-180, 2005 | 205 | 2005 |
